1. p-Guanidino-and p-guanidinomethyl-phenylalanine increase the renal excretion of lysine especially and, to some extent, cystine in the phenylalanine-loaded rat. The methyl derivative is the more effective.
Introduction
Dibasic monocarboxylic amino acids have been postulated to share a common but discrete renal transport mechanism in the rat (Bergeron & Morel, 1969) and it has been suggested that qualification for similar transport in humans depends on the spatial arrangement of protonated groups in the molecules involved (Dent & Rose, 1951) . During studies of phenylalanine reabsorption after intravenous infusion of p-amino-and p-guanidinoCorrespondence: Dr C. W. I. Owens, Medical Unit, University College Hospital Medical School, University Street, London WC IE 6JJ. substituted phenylalanines (each involving two rats), the guanidino derivatives produced a basic aminoaciduria whereas the p-amino analogues did not (Owens, 1977) . Infusion of approximately 10 and 25 /imol min -1 kg -1 of pguanidinophenylalanine (GPA) and more par ticularly p-guanidinomethylphenylalanine (GMPA) increased urinary excretion of lysine up to 40-fold with smaller effects on cystine and arginine. The present investigation was undertaken to extend this finding, which reveals two substances poten tially valuable in the study of basic amino acid transport.
Methods
Basic amino acids were measured in the urine of phenylalanine-loaded ethanol-anaesthetized rats during intravenous infusion of GPA and GMPA (Owens, 1977) . Female Wistar rats (180-210 g) were anaesthetized with oral aqueous ethanol (15%, v/v) in divided doses of 3-5 g/kg. After bladder catheterization animals were loaded intravenously with phenylalanine in hypotonic saline (151-5 μπιοΐ/ml) for 70 min at 0-143 ml/min, and then maintained on phenylalanine at 3-48 /imol/ml. Fifty minutes later GPA or GMPA was added so that initially 2 μτηοΐ and then 5/imol was infused each minute for 50 min. There was a 40 min re-equilibration period between analogue infusions.
Urine was collected for 10 min periods before, during and after analogue infusions (Table 1) and amino acid concentrations were determined by ionexchange chromatography, ninhydrin colour formation being used with norleucine as an internal standard. Amino acids were chromatographed with sodium citrate buffers, 0-2 mol/1 and 1 -0 mol/1 with respect to sodium (Spackman, Stein & Moore, 1958; Owens, 1977) , or by gradient elution (D. Perrett, unpublished method) from a column (15 cm x 0·9 cm diam.) containing cation-exchange resin Locarte LA49 (8 μηα) maintained at 60°C and with a modified Technicon NCI amino acid analyser. The gradient was created by using a flow of 36 ml/h from a 9 x 50 ml chamber Autogradloaded with sodium citrate (0-05 mol/1), pH 2·85, in the first five chambers and sodium citrate (0-2 mol/1), pH 4· 75, in the next four. Urinary sodium concentration was determined by atomic absorption spectrometry Owens, 1977) .
Results are expressed as mean value ± 1 SEM.
Results
Rates of lysine and cystine excretion (Table 1) increased during intravenous infusion of GPA but more especially with GMPA. The effect was doserelated, reversible and reached a 40-fold increase for lysine in a single animal receiving 4 /nnol of GMPA/min during its first analogue infusion. Arginine excretion increased to a slight extent whereas ornithine and histidine were virtually unaffected. To test this relationship further two animals were loaded, allowed to equilibrate for 50 min and then infused for five consecutive 10 min periods with doses of GPA or GMPA, which increased pro gressively by ljumol/min for each consecutive period. Urinary lysine excretion during these infusions of 1, 2, 3, 4 and 5 μταοΐ of GPA/min was 8, 12, 67, 125 and 181 nmol/min respectively. With GMPA lysine excretion was 6, 15, 88 and 205 nmol/min in the first four periods. Cystine, analysed as cysteic acid (Dent, 1948) in this multidose experiment, was excreted during the infusions at 13, 12, 26, 33,47 and 5, 8, 13 and 34 nmol/min for GPA and GMPA respectively.
There was no significant correlation overall between lysine excretion and either urine flow (mean 0-071 + 0-01 ml/min, « = 34) or sodium excretion (mean 2-57 + 0-40 ,umol/min, n = 34). In four animals plasma lysine concentration (mean 0-36 ± 0-03 mmol/1, n = 7) did not correlate with the concentration of analogue infused.
Discussion
Infusion of the analogues p-guanidino-and pguanidinomethyl-phenylalanine into phenylalanineloaded rats can increase urinary excretion of lysine 40 times and of cystine by 17 times. Intravenous cycloleucine (approximately 2-3 mmol day -1 kg -1 ) in man (Brown, 1967) and an intraperitoneal injection of a^aminoisobutyric acid (10 mmol/kg) in rats (Christensen & Cullen, 1968) also increase clearance of lysine and cystine without elevating plasma concentrations. However, cycloleucine also causes ornithinuria and argininuria and a^aminoisobutyrate primarily cystinuria. Both cause a neutral aminoaciduria and neither of them produces the relatively selective lysinecystinuria seen here.
These analogues appear to affect the lysine/cystine shared transport mechanism that is suggested by the lysine excretion in homozygous cystinuria (Arrow & Westall, 1958) and also by clearance studies in both man (Robson & Rose, 1957) and dog (Ruszkowski, Arasimowicz, Knapowski, Steffen & Weiss, 1962) . Lysine, however, seems preferentially involved in these rats where there may not be a common transport pathway for these two amino acids (Segal & Smith, 1969; Wilson & Scriver, 1967; Rosenberg, Down ing & Segal, 1962) . The small effect on arginine excretion, although implying selectivity, may arise from efficient arginine reabsorption seen in the rat (Rosenberg et ai, 1962) . Dissociation of lysine and cystine excretion is also seen in human cystinuria where there is a net secretion of cystine in the presence of continuing lysine reabsorption (Crawhall, Scowen, Thompson & Watts, 1967) . In the 'pure' cystinuria of humans (Brodehl, Gellissen & Kowalewski, 1967) and the blotched genet (Genetta tigrina) (Datta & Harris, 1953; Elliott, Ribeira & Eusebio, 1968) and in a human basic aminoaciduria (Whelan & Scriver, 1968) lysinuria is dissociated from cystinuria.
p-Guanidinomethylphenylalanine has its second acid dissociation constant (pK 2 8-61) closer to that of lysine (pK 2 8-83) (Owens, ten-Krooden & Grzybowski, 1977) than does pguanidinophenylalanine (pK 2 8-44), but neither value is far removed from that of paminomethylphenylalanine (pJf 2 8-40), which does not cause lysinuria (Owens, 1977) . At physio logical pH the amino groups of all the analogues will be protonated and presumably near to the spatial requirements (Dent & Rose, 1951) for transport in the basic amino acid system. Whether the methyl bridge in the guanidino derivatives influences lysine excretion by facilitating critical steric arrangement or by merely increasing the protonation of the terminal guanidino nitrogen atom is not clear. Spatial arrangements, however, seem important because insertion of a -CH 2 -group at C-4 of l-guanyl-4-aminopiperidine-4-carboxylic acid to form 1-guanylpiperidine-glycine causes a reduction in the induced lysinuria from 200 times to seven times that of a control (Christensen & Cullen, 1973) . Furthermore it may be relevant that three-dimensional models of effective analogues (Owens, 1977; Christensen & Cullen, 1973) can be folded into a closed con figuration with the protonated groups approxi mately 4 x 10 _1 nm apart, as compared with a minimum distance of 2-5 x 10 _1 nm, which can be achieved with lysine. Ineffective analogues cannot be folded so closely. Models of homoarginine and α,ε-diaminopimelic acid, both of which cause lysinuria, fold appropriately but the latter (which is less effective) has two negatively charged groups as opposed to one. If the receptor site requires two protonated groups critically spaced about 3 x 10" 1 nm apart then cw-l-amino-4-amidinomethylcyclohexane-1-carboxylic acid and 1-amino-4-guanidinoethylpiperidine-l-carboxylicacid should produce a marked lysinuria.
Incidentally, although the guanidino group is considered a point of recognition for arginine transport in Salmonella typhimurium (Quay & Christensen, 1974) , 10 min infusions of guanidinoalanine and aminoethylcysteine (a lysine antagonist) into single animals had no effect on arginine, alanine or lysine reabsorption.
The compounds described here resemble α,ε-diaminopimelic acid in producing a lysinuria with out marked argininuria or ornithinuria. The slight increase of urinary histidine is probably a non specific effect secondary to the increased filtered α-aminocarboxylic load. Neither analogue pro duces a detectable citrullinuria, unlike 4-piperidineglycine and lysine (Christensen & Cullen, 1973) . They did not contain lysine or cause a lysinaemia and did not consistently alter urine flow or urinary sodium concentration. Whether they in crease plasma glucagon and insulin, as can piperidine derivatives (Christensen & Cullen, 1973) , arginine or lysine, is not known. It is also unknown if the associated cystinuria results from secondary inhibition of cystine efflux from the tubular cell into the plasma, or through effects on shared transport. These compounds may be of some use in the elucidation of basic amino acidtransport mechanisms.
